1,396 research outputs found
Recommended from our members
A pilot study evaluating the effects of a 12 week exergaming programme on body mass, size and composition in postpartum females
Introduction: Pregnancy is associated with weight gain, the retention of which contributes to the prevalence of obesity and overweight in adult females. Many new mothers do not achieve the recommendations for physical activity (PA), citing factors such as a lack of time and access to childcare. Exergaming may address some of the barriers to PA and offer an alternative to traditional exercise, thus aiding in weight management. The aim of this pilot study was to evaluate the effects of an exergaming intervention on body composition in postpartum females. Methods: Eight females who had given birth within 1 year completed a 12 week exergaming intervention, which required them to exercise at home for 45 minutes on alternate days, using the Wii Fit. Participants self-reported their pre-pregnancy body weight, and visited the laboratory prior to and following the intervention for evaluation of body
weight, size (height, regional circumferences, body mass index [BMI]) and composition (fat mass [FM], lean mass [LM] and bone mineral content [BMC]). Body composition was evaluated via full body full-body dual-energy x-ray
absorptiometry scan. Participants completed a three-day weighed food intake at three time-points. Results: Baseline body mass was 8.2 kg greater than self-reported pre-pregnancy values (56.8 ± 5.1 kg). Following the
intervention, body mass was significantly lower than baseline values and was similar to pre-pregnancy levels (59.9 ± 7.9 kg). Reductions in BMI (~2 kg·m2
), waist, hip and bust circumference (3-6%) accompanied the loss of body mass. Food diaries confirmed participants had not altered their energy intake.
Discussion: The results of this pilot study indicate that exergaming may offer an alternative to traditional exercise for preventing the retention of gestational weight gain and reducing associated health risks, whilst also maintaining lean mass and bone mineral content
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
A series of hydroxamates, which are not metalloprotease inhibitors, have been found to be selectively toxic to a range of transformed and human tumour cells without killing normal cells (fibroblasts, melanocytes) at the same concentrations. Within 24 h of treatment, drug action is characterized by morphological reversion of tumour cells to a more normal phenotype (dendritic morphology), and rapid and reversible acetylation of histone H4 in both tumour and normal cells. Two; hydroxamates inhibited growth of xenografts of human melanoma cells in nude mice; resistance did not develop in vivo or in vitro. A third hydroxamate, trichostatin A, was active in vitro but became inactivated and had no anti-tumour activity in vivo. Development of dendritic morphology was found to be dependent upon phosphatase activity, RNA and protein synthesis. Proliferating hybrid clones of sensitive and resistant cells remained sensitive to ABHA, indicating a dominant-negative mechanism of sensitivity. Histone H4 hyperacetylation suggests that these agents act at the chromatin level. This work may lead to new drugs that are potent, and selective anti-tumour agents with low toxicity to normal Cells
Toward a Better Understanding of Non-Addicted, Methamphetamine-Using, Men who Have Sex with Men (MSM) in Atlanta
Methamphetamine use has increasingly become linked with sexual risk behaviors among men have sex with men (MSM). Yet, the majority of research has been done with methamphetamine dependent MSM or with samples in which addiction to the substance was not evaluated. Furthermore, research with methamphetamine-using MSM in the Southern U.S. is lacking. In this study, focus groups and in-depth interviews were conducted in order to understand the motives, context, and other facilitators and barriers of methamphetamine use among non-addicted MSM residing in Atlanta. Participants included 30 non-addicted, methamphetamine-using MSM and 16 local mental and public health officials. Findings from the first of this two-phase formative research project will result in the initial development of a community-tested, culturally-specific social marketing campaign and an individual-based intervention based in HIV-testing facilities
Population Genetics of Franciscana Dolphins (Pontoporia blainvillei): Introducing a New Population from the Southern Edge of Their Distribution
Due to anthropogenic factors, the franciscana dolphin, Pontoporia blainvillei, is the most threatened small cetacean on the Atlantic coast of South America. Four Franciscana Management Areas have been proposed: Espiritu Santo to Rio de Janeiro (FMA I), SĂŁo Paulo to Santa Catarina (FMA II), Rio Grande do Sul to Uruguay (FMA III), and Argentina (FMA IV). Further genetic studies distinguished additional populations within these FMAs. We analyzed the population structure, phylogeography, and demographic history in the southernmost portion of the species range. From the analysis of mitochondrial DNA control region sequences, 5 novel haplotypes were found, totalizing 60 haplotypes for the entire distribution range. The haplotype network did not show an apparent phylogeographical signal for the southern FMAs. Two populations were identified: Monte Hermoso (MH) and Necochea (NC)+ClaromecĂł (CL)+RĂo Negro (RN). The low levels of genetic variability, the relative constant size over time, and the low levels of gene flow may indicate that MH has been colonized by a few maternal lineages and became isolated from geographically close populations. The apparent increase in NC+CL+RN size would be consistent with the higher genetic variability found, since genetic diversity is generally higher in older and expanding populations. Additionally, RN may have experienced a recent split from CL and NC; current high levels of gene flow may be occurring between the latter ones. FMA IV would comprise four franciscana dolphin populations: SamborombĂłn West+SamborombĂłn South, Cabo San Antonio+Buenos Aires East, NC+CL+Buenos Aires Southwest+RN and MH. Results achieved in this study need to be taken into account in order to ensure the long-term survival of the species.Fil: Gariboldi, MarĂa Constanza. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; Argentina. Universidad MaimĂłnides. Ărea de Investigaciones BiomĂ©dicas y BiotecnolĂłgicas. Centro de Estudios BiomĂ©dicos, BiotecnolĂłgicos, Ambientales y de DiagnĂłstico; ArgentinaFil: Tunez, Juan Ignacio. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; Argentina. Universidad Nacional de LujĂĄn; ArgentinaFil: Dejean, Cristina Beatriz. Universidad MaimĂłnides. Ărea de Investigaciones BiomĂ©dicas y BiotecnolĂłgicas. Centro de Estudios BiomĂ©dicos, BiotecnolĂłgicos, Ambientales y de DiagnĂłstico; Argentina. Universidad de Buenos Aires. Facultad de FilosofĂa y Letras. Instituto de Ciencias AntropolĂłgicas. SecciĂłn AntropologĂa BiolĂłgica; ArgentinaFil: Failla, Mauricio. FundaciĂłn Cethus; ArgentinaFil: Vitullo, Alfredo Daniel. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; Argentina. Universidad MaimĂłnides. Ărea de Investigaciones BiomĂ©dicas y BiotecnolĂłgicas. Centro de Estudios BiomĂ©dicos, BiotecnolĂłgicos, Ambientales y de DiagnĂłstico; ArgentinaFil: Negri, Maria Fernanda. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; Argentina. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Parque Centenario. Museo Argentino de Ciencias Naturales ; ArgentinaFil: Cappozzo, Humberto Luis. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; Argentina. Universidad MaimĂłnides. Ărea de Investigaciones BiomĂ©dicas y BiotecnolĂłgicas. Centro de Estudios BiomĂ©dicos, BiotecnolĂłgicos, Ambientales y de DiagnĂłstico; Argentina. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Parque Centenario. Museo Argentino de Ciencias Naturales ; Argentin
Recommended from our members
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report.
The vocabulary currently used to describe genetic variants and their consequences reflects many years of studying and discovering monogenic disease with high penetrance. With the recent rapid expansion of genetic testing brought about by wide availability of high-throughput massively parallel sequencing platforms, accurate variant interpretation has become a major issue. The vocabulary used to describe single genetic variants in silico, in vitro, in vivo and as a contributor to human disease uses terms in common, but the meaning is not necessarily shared across all these contexts. In the setting of cancer genetic tests, the added dimension of using data from genetic sequencing of tumour DNA to direct treatment is an additional source of confusion to those who are not experienced in cancer genetics. The language used to describe variants identified in cancer susceptibility genetic testing typically still reflects an outdated paradigm of Mendelian inheritance with dichotomous outcomes. Cancer is a common disease with complex genetic architecture; an improved lexicon is required to better communicate among scientists, clinicians and patients, the risks and implications of genetic variants detected. This review arises from a recognition of, and discussion about, inconsistencies in vocabulary usage by members of the ENIGMA international multidisciplinary consortium focused on variant classification in breast-ovarian cancer susceptibility genes. It sets out the vocabulary commonly used in genetic variant interpretation and reporting, and suggests a framework for a common vocabulary that may facilitate understanding and clarity in clinical reporting of germline genetic tests for cancer susceptibility
Protocol for a randomised controlled trial of an outreach support program for family carers of older people discharged from hospital
Background: Presentations to hospital of older people receiving family care at home incur substantial costs for patients, families, and the health care system, yet there can be positive carer outcomes when systematically assessing/addressing their support needs, and reductions in older people's returns to hospital attributed to appropriate discharge planning. This study will trial the Further Enabling Care at Home program, a 2-week telephone outreach initiative for family carers of older people returning home from hospital. Hypotheses are that the program will (a) better prepare families to sustain their caregiving role and (b) reduce patients' re-presentations/readmissions to hospital, and/or their length of stay; also that reduced health system costs attributable to the program will outweigh costs of its implementation. Methods/Design: In this randomised controlled trial, family carers of older patients aged 70+ discharged from a Medical Assessment Unit in a Western Australian tertiary hospital, plus the patients themselves, will be recruited at discharge (N = 180 dyads). Carers will be randomly assigned (block allocation, assessors blinded) to receive usual care (control) or the new program (intervention). The primary outcome is the carer's self-reported preparedness for caregiving (Preparedness for Caregiving Scale administered within 4 days of discharge, 2-3 weeks post-discharge, 6 weeks post-discharge). To detect a clinically meaningful change of two points with 80 % power, 126 carers need to complete the study. Patients' returns to hospital and subsequent length of stay will be ascertained for a minimum of 3 months after the index admission. Regression analyses will be used to determine differences in carer and patient outcomes over time associated with the group (intervention or control). Data will be analysed using an Intention to Treat approach. A qualitative exploration will examine patients' and their family carers' experiences of the new program (interviews) and explore the hospital staff's perceptions (focus groups). Process evaluation will identify barriers to, and facilitators of, program implementation. A comprehensive economic evaluation will determine cost consequences. Discussion: This study investigates a novel approach to identifying and addressing family carers' needs following discharge from hospital of the older person receiving care. If successful, the program has potential to be incorporated into routine post-discharge support. Trial registration: Australian and New Zealand Clinical Trial Registry: ACTRN12614001174673
Safety of opioids in osteoarthritis: Outcomes of a systematic review and meta-analysis
Objective: We aimed to assess the safety of opioids in the management of osteoarthritis (OA) in a systematic review and meta-analysis of randomized, placebo-controlled trials.
Methods: A comprehensive literature search was undertaken in the MEDLINE, Cochrane Central Register of Controlled Trials (Ovid CENTRAL), and Scopus electronic databases. Randomized, double-blind, placebo-controlled, parallel-group trials that assessed adverse events (AEs) with opioids in patients with OA were eligible for inclusion. Two authors appraised titles, abstracts and full-text papers for suitability and then assessed the studies for random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data and selective outcomes reporting. The primary outcomes of interest were gastrointestinal (GI) disorders, cardiac disorders, vascular disorders, nervous system disorders, skin and subcutaneous tissue disorders, renal and urinary disorders, respiratory, thoracic and mediastinal disorders, as well as overall severe and serious AEs and drug-related AEs. Secondary outcomes were withdrawals due to AEs (i.e. the number of participants who stopped the treatment due to an AE) and total number of AEs (i.e. the number of patients who experienced any AE at least once).
Results: Database searches identified 2189 records, from which, after exclusions, 17 papers were included in the meta-analysis. More disorders of the lower GI tract (constipation, fecaloma) were reported with both immediate-release (IR) and extended-release (ER) formulations of opioids versus placebo: IR opioids (relative risk [RR] 5.20, 95% confidence interval [CI] 3.42â7.89); ER opioids (RR 4.22, 95% CI 3.44â5.17). The risk of upper GI AEs increased fourfold with ER opioids compared with placebo (RR 4.03, 95% CI 0.87â18.62), and the risk of nausea, vomiting or loss of appetite increased four- to fivefold with both formulations: IR opioids (RR 3.39, 95% CI 2.22â5.18); ER opioids (RR 4.03, 95% CI 3.37â4.83). An increased risk of dermatologic AEs (rash and pruritis; IR opioids: RR 3.60, 95% CI 1.74â7.43; ER opioids: RR 7.87, 95% CI 5.20â11.89) and central nervous system disorders (dizziness, headache, fatigue, somnolence, insomnia; IR opioids: RR 2.76, 95% CI 1.90â4.02; ER opioids: RR 2.76, 95% CI 2.19â3.47) was found with all opioid formulations versus placebo.
Conclusions: Our results confirm that there are considerable safety and tolerability issues surrounding the use of opioids in OA, and support the recommendation of international and national guidelines to use opioids in OA after other analgesic options, and for short time periods
Enhancing the Scientific Value of Industry Remotely Operated Vehicles (ROVs) in Our Oceans
© Copyright © 2020 McLean, Parsons, Gates, Benfield, Bond, Booth, Bunce, Fowler, Harvey, Macreadie, Pattiaratchi, Rouse, Partridge, Thomson, Todd and Jones. Remotely operated vehicles (ROVs) are used extensively by the offshore oil and gas and renewables industries for inspection, maintenance, and repair of their infrastructure. With thousands of subsea structures monitored across the worldâs oceans from the shallows to depths greater than 1,000 m, there is a great and underutilized opportunity for their scientific use. Through slight modifications of ROV operations, and by augmenting industry workclass ROVs with a range of scientific equipment, industry can fuel scientific discoveries, contribute to an understanding of the impact of artificial structures in our oceans, and collect biotic and abiotic data to support our understanding of how oceans and marine life are changing. Here, we identify and describe operationally feasible methods to adjust the way in which industry ROVs are operated to enhance the scientific value of data that they collect, without significantly impacting scheduling or adding to deployment costs. These include: rapid marine life survey protocols, imaging improvements, the addition of a range of scientific sensors, and collection of biological samples. By partnering with qualified and experienced research scientists, industry can improve the quality of their ROV-derived data, allowing the data to be analyzed robustly. Small changes by industry now could provide substantial benefits to scientific research in the long-term and improve the quality of scientific data in existence once the structures require decommissioning. Such changes also have the potential to enhance industryâs environmental stewardship by improving their environmental management and facilitating more informed engagement with a range of external stakeholders, including regulators and the public
Ambivalent connections: a qualitative study of the care experiences of non-psychotic chronic patients who are perceived as 'difficult' by professionals
Contains fulltext :
90688.pdf (publisher's version ) (Open Access)Background: Little is known about the perspectives of psychiatric patients who are perceived as 'difficult' by clinicians. The aim of this paper is to improve understanding of the connections between patients and professionals from patients' point of view.
Methods: A Grounded Theory study using interviews with 21 patients from 12 outpatient departments of three mental health care facilities.
Results: Patients reported on their own difficult behaviours and their difficulties with clinicians and services. Explanations varied but could be summarized as a perceived lack of recognition. Recognition referred to being seen as a patient and a person - not just as completely 'ill' or as completely 'healthy'. Also, we found that patients and professionals have very different expectations of one another, which may culminate in a difficult or ambivalent connection. In order to explicate patient's expectations, the patient-clinician contact was described by a stage model that differentiates between three stages of contact development, and three stages of substantial treatment. According to patients, in each stage there is a therapeutic window of optimal clinician behaviour and two wider spaces below and above that may be qualified as 'toxic' behaviour. Possible changes in clinicians' responses to 'difficult' patients were described using this model.
Conclusions: The incongruence of patients' and professionals' expectations may result in power struggles that may make professionals perceive patients as 'difficult'. Explication of mutual expectations may be useful in such cases. The presented model gives some directions to clinicians how to do this.11 p
Measurement of the inclusive and dijet cross-sections of b-jets in pp collisions at sqrt(s) = 7 TeV with the ATLAS detector
The inclusive and dijet production cross-sections have been measured for jets
containing b-hadrons (b-jets) in proton-proton collisions at a centre-of-mass
energy of sqrt(s) = 7 TeV, using the ATLAS detector at the LHC. The
measurements use data corresponding to an integrated luminosity of 34 pb^-1.
The b-jets are identified using either a lifetime-based method, where secondary
decay vertices of b-hadrons in jets are reconstructed using information from
the tracking detectors, or a muon-based method where the presence of a muon is
used to identify semileptonic decays of b-hadrons inside jets. The inclusive
b-jet cross-section is measured as a function of transverse momentum in the
range 20 < pT < 400 GeV and rapidity in the range |y| < 2.1. The bbbar-dijet
cross-section is measured as a function of the dijet invariant mass in the
range 110 < m_jj < 760 GeV, the azimuthal angle difference between the two jets
and the angular variable chi in two dijet mass regions. The results are
compared with next-to-leading-order QCD predictions. Good agreement is observed
between the measured cross-sections and the predictions obtained using POWHEG +
Pythia. MC@NLO + Herwig shows good agreement with the measured bbbar-dijet
cross-section. However, it does not reproduce the measured inclusive
cross-section well, particularly for central b-jets with large transverse
momenta.Comment: 10 pages plus author list (21 pages total), 8 figures, 1 table, final
version published in European Physical Journal
- âŠ